LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

Historical Holders from Q1 2021 to Q3 2025

Symbol
LVTX
Type / Class
Equity / Common shares, Euro 0.12 nominal value per share
Shares outstanding
26,019,256
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
10,325,473
Holdings value
$16,107,942
% of all portfolios
0%
Number of holders
21
Number of buys
10
Number of sells
-6
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Shay Capital LLC 9.9% $3,972,497 2,596,403 Shay Capital LLC 19 Sep 2025
BML Investment Partners, L.P. 7.4% $2,702,192 1,958,110 BML Investment Partners, L.P. 26 Feb 2025
Cooperatieve Gilde Healthcare IV U.A. 3.9% -66.4% $1,561,194 -$2,973,967 1,014,751 -65.6% Cooperatieve Gilde Healthcare IV U.A. 20 Oct 2025

Institutional Holders of LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 10,325,473 $16,107,942 +$3,784,170 $1.56 21
2025 Q2 8,051,831 $10,628,889 +$10,808 $1.32 19
2025 Q1 8,044,890 $10,217,501 +$2,034,483 $1.27 20
2024 Q4 6,472,867 $6,154,436 -$431,783 $0.951 21
2024 Q3 3,608,399 $5,990,569 -$252,767 $1.66 20
2024 Q2 3,758,209 $6,765,357 -$68,179 $1.8 18
2024 Q1 3,761,071 $12,523,082 -$2,095,770 $3.33 20
2023 Q4 5,835,438 $9,220,360 +$207,107 $1.58 13
2023 Q3 5,718,284 $8,466,900 -$47,237 $1.49 13
2023 Q2 5,746,405 $11,664,321 -$1,820,221 $2.03 15
2023 Q1 6,739,420 $11,188,178 -$1,628,916 $1.66 19
2022 Q4 7,455,727 $26,310,745 +$104,767 $3.5 19
2022 Q3 7,452,823 $34,059,026 -$58,911 $4.57 12
2022 Q2 7,839,304 $22,812,045 -$450,030 $2.95 16
2022 Q1 7,995,442 $35,178,298 -$409,457 $4.4 16
2021 Q4 8,054,131 $44,296,000 -$913,618 $5.5 18
2021 Q3 8,217,728 $48,648,000 -$5,131,867 $5.92 17
2021 Q2 8,772,945 $95,450,000 -$5,974,989 $10.88 18
2021 Q1 9,222,819 $139,085,000 +$139,085,000 $15.19 24